These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23023701)

  • 21. NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma.
    Hu S; Molina L; Tao J; Liu S; Hassan M; Singh S; Poddar M; Bell A; Sia D; Oertel M; Raeman R; Nejak-Bowen K; Singhi A; Luo J; Monga SP; Ko S
    Gastroenterology; 2022 Aug; 163(2):449-465. PubMed ID: 35550144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wntless Is Highly Expressed in Advanced-Stage Intrahepatic Cholangiocarcinoma.
    Shi Y; Bai J; Guo S; Wang J
    Tohoku J Exp Med; 2018 Mar; 244(3):195-199. PubMed ID: 29526886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.
    Xue TC; Zhang BH; Ye SL; Ren ZG
    Tumour Biol; 2015 Aug; 36(8):5891-9. PubMed ID: 25712376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
    Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
    Ishikawa K; Sasaki A; Haraguchi N; Yoshikawa Y; Mori M
    Oncologist; 2007 Mar; 12(3):320-4. PubMed ID: 17405896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
    Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma of possibly hepatic progenitor cell origin in a cow.
    Ohfuji S
    Vet Q; 2012; 32(3-4):183-6. PubMed ID: 23215835
    [No Abstract]   [Full Text] [Related]  

  • 28. Allelotypic characteristics of thorotrast-induced intrahepatic cholangiocarcinoma: comparison to liver cancers not associated with thorotrast.
    Liu D; Wada I; Tateno H; Ogino D; Suzuki M; Li L; Lu W; Kojiro M; Fukayama M; Okabe H; Fukumoto M
    Radiat Res; 2004 Feb; 161(2):235-43. PubMed ID: 14731065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype.
    Nomoto K; Tsuneyama K; Cheng C; Takahashi H; Hori R; Murai Y; Takano Y
    Pathol Res Pract; 2006; 202(2):71-6. PubMed ID: 16377099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
    Sia D; Villanueva A; Friedman SL; Llovet JM
    Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m
    Zhou S; Yang K; Chen S; Lian G; Huang Y; Yao H; Zhao Y; Huang K; Yin D; Lin H; Li Y
    J Transl Med; 2023 Jan; 21(1):43. PubMed ID: 36691046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
    Aishima S; Oda Y
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target.
    Saborowski A; Saborowski M; Davare MA; Druker BJ; Klimstra DS; Lowe SW
    Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19513-8. PubMed ID: 24154728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway.
    Shen J; Zhou Y; Zhang X; Peng W; Peng C; Zhou Q; Li C; Wen T; Shi Y
    Aging (Albany NY); 2019 Nov; 11(21):9280-9294. PubMed ID: 31689237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review).
    Bogaerts E; Heindryckx F; Vandewynckel YP; Van Grunsven LA; Van Vlierberghe H
    Int J Oncol; 2014 Apr; 44(4):1015-22. PubMed ID: 24504124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
    Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
    Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
    Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
    World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
    Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
    Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
    Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
    Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.